Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Vaccines

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 127 articles: HTML format

Single Articles

May 2008
1. HALASA NB , Gerber MA, Chen Q, Wright PF, et al
   Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants.
   J Infect Dis. 2008;197:1448-1454.
   PubMed     Related articles    Abstract available
   
   
   
2. LU CY , Ni YH, Chiang BL, Chen PJ, et al
   Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.
   J Infect Dis. 2008;197:1419-26.
   PubMed     Related articles    Abstract available
   
   
   
3. VOGT TM , Wise ME, Bell BP, Finelli L, et al
   Declining Hepatitis A Mortality in the United States during the Era of Hepatitis A Vaccination.
   J Infect Dis. 2008;197:1282-8.
   PubMed     Related articles    Abstract available
   
   
   
4. TANG C , Yamada H, Shibata K, Maeda N, et al
   Efficacy of Recombinant Bacille Calmette-Guerin Vaccine Secreting Interleukin-15/Antigen 85B Fusion Protein in Providing Protection against Mycobacterium tuberculosis.
   J Infect Dis. 2008;197:1263-1274.
   PubMed     Related articles    Abstract available
   
   
   
5. DIENSTAG JL
   Hepatitis a: the vaccine dividend.
   J Infect Dis. 2008;197:1220-2.
   PubMed     Related articles   
   
   
   April 2008
6. GO V , Pollard RB
   A Cytomegalovirus Vaccine for Transplantation: Are We Closer?
   J Infect Dis. 2008;.
   PubMed     Related articles   
   
   
   
7. WLOCH MK , Smith LR, Boutsaboualoy S, Reyes L, et al
   Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects.
   J Infect Dis. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. DATE AA , Kyaw MH, Rue AM, Klahn J, et al
   Long-Term Persistence of Mumps Antibody after Receipt of 2 Measles-Mumps-Rubella (MMR) Vaccinations and Antibody Response after a Third MMR Vaccination among a University Population.
   J Infect Dis. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. HANNA-WAKIM R , Yasukawa LL, Sung P, Arvin AM, et al
   Immune Responses to Mumps Vaccine in Adults Who Were Vaccinated in Childhood.
   J Infect Dis. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. BAE HG , Domingo C, Tenorio A, Ory FD, et al
    Immune Response during Adverse Events after 17D-Derived Yellow Fever Vaccination in Europe.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. TROTTIER H , Mahmud S, Prado JC, Sobrinho JS, et al
    Type-Specific Duration of Human Papillomavirus Infection: Implications for Human Papillomavirus Screening and Vaccination.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. RAKOTO-ANDRIANARIVELO M , Gumede N, Jegouic S, Balanant J, et al
    Reemergence of Recombinant Vaccine-Derived Poliovirus Outbreak in Madagascar.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. WELSCH JA , Ram S, Koeberling O, Granoff DM, et al
    Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen.
    J Infect Dis. 2008;197:1053-61.
    PubMed     Related articles    Abstract available
    
    
    
14. MICHALIK DE , Steinberg SP, Larussa PS, Edwards KM, et al
    Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
    J Infect Dis. 2008;197:944-9.
    PubMed     Related articles    Abstract available
    
    
    
15. SHAPIRO ED
    Second dose of varicella vaccine for children: are we giving it too late?
    J Infect Dis. 2008;197:935-7.
    PubMed     Related articles   
    
    
    
16. SPELLBERG B , Ibrahim AS, Lin L, Avanesian V, et al
    Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity.
    J Infect Dis. 2008;197:967-71.
    PubMed     Related articles    Abstract available
    
    
    
17. DAVIDKIN I , Jokinen S, Broman M, Leinikki P, et al
    Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    J Infect Dis. 2008;197:950-6.
    PubMed     Related articles    Abstract available
    
    
    
18. GALGIANI JN
    Vaccines to prevent systemic mycoses: holy grails meet translational realities.
    J Infect Dis. 2008;197:938-40.
    PubMed     Related articles   
    
    
    March 2008
19. LEVIN MJ , Oxman MN, Zhang JH, Johnson GR, et al
    Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.
    J Infect Dis. 2008;197:825-35.
    PubMed     Related articles    Abstract available
    
    
    
20. SEWARD JF , Marin M, Vazquez M
    Varicella vaccine effectiveness in the US vaccination program: a review.
    J Infect Dis. 2008;197 Suppl 2:S82-9.
    PubMed     Related articles    Abstract available
    
    
    
21. LOPEZ AS , Kolasa MS, Seward JF
    Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program.
    J Infect Dis. 2008;197 Suppl 2:S76-81.
    PubMed     Related articles    Abstract available
    
    
    
22. CARBAJAL T , Civen R, Reynolds M, Chaves SS, et al
    Knowledge, attitudes, and practices regarding varicella vaccination among health care providers participating in the varicella active surveillance project, Antelope Valley, California, 2005.
    J Infect Dis. 2008;197 Suppl 2:S66-70.
    PubMed     Related articles    Abstract available
    
    
    
23. BREUER J , Schmid DS
    Vaccine oka variants and sequence variability in vaccine-related skin lesions.
    J Infect Dis. 2008;197 Suppl 2:S54-7.
    PubMed     Related articles    Abstract available
    
    
    
24. STORLIE J , Maresova L, Jackson W, Grose C, et al
    Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus.
    J Infect Dis. 2008;197 Suppl 2:S49-53.
    PubMed     Related articles    Abstract available
    
    
    
25. YAMANISHI K
    Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
    J Infect Dis. 2008;197 Suppl 2:S45-8.
    PubMed     Related articles    Abstract available
    
    
    
26. TAKAHASHI M , Asano Y, Kamiya H, Baba K, et al
    Development of varicella vaccine.
    J Infect Dis. 2008;197 Suppl 2:S41-4.
    PubMed     Related articles    Abstract available
    
    
    
27. GERSHON AA , Arvin AM, Levin MJ, Seward JF, et al
    Varicella vaccine in the United States: a decade of prevention and the way forward.
    J Infect Dis. 2008;197 Suppl 2:S39-40.
    PubMed     Related articles   
    
    
    
28. GERSHON AA , Katz SL
    Perspective on live varicella vaccine.
    J Infect Dis. 2008;197 Suppl 2:S242-5.
    PubMed     Related articles    Abstract available
    
    
    
29. COHEN JI
    Strategies for herpes zoster vaccination of immunocompromised patients.
    J Infect Dis. 2008;197 Suppl 2:S237-41.
    PubMed     Related articles    Abstract available
    
    
    
30. OXMAN MN , Levin MJ
    Vaccination against Herpes Zoster and Postherpetic Neuralgia.
    J Infect Dis. 2008;197 Suppl 2:S228-36.
    PubMed     Related articles    Abstract available
    
    
    
31. REYNOLDS MA , Chaves SS, Harpaz R, Lopez AS, et al
    The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    J Infect Dis. 2008;197 Suppl 2:S224-7.
    PubMed     Related articles    Abstract available
    
    
    
32. HURLEY LP , Harpaz R, Daley MF, Crane LA, et al
    National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine.
    J Infect Dis. 2008;197 Suppl 2:S216-23.
    PubMed     Related articles    Abstract available
    
    
    
33. SCHMADER K , Gnann JW Jr, Watson CP
    The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine.
    J Infect Dis. 2008;197 Suppl 2:S207-15.
    PubMed     Related articles    Abstract available
    
    
    
34. LEVIN MJ
    Varicella vaccination of immunocompromised children.
    J Infect Dis. 2008;197 Suppl 2:S200-6.
    PubMed     Related articles    Abstract available
    
    
    
35. HAMBLETON S , Steinberg SP, Larussa PS, Shapiro ED, et al
    Risk of herpes zoster in adults immunized with varicella vaccine.
    J Infect Dis. 2008;197 Suppl 2:S196-9.
    PubMed     Related articles    Abstract available
    
    
    
36. MACARTNEY KK , Burgess MA
    Varicella vaccination in Australia and New Zealand.
    J Infect Dis. 2008;197 Suppl 2:S191-5.
    PubMed     Related articles    Abstract available
    
    
    
37. SADZOT-DELVAUX C , Rentier B, Wutzler P, Asano Y, et al
    Varicella vaccination in Japan, South Korea, and Europe.
    J Infect Dis. 2008;197 Suppl 2:S185-90.
    PubMed     Related articles    Abstract available
    
    
    
38. WILSON E , Goss MA, Marin M, Shields KE, et al
    Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry.
    J Infect Dis. 2008;197 Suppl 2:S178-84.
    PubMed     Related articles    Abstract available
    
    
    
39. CHAVES SS , Haber P, Walton K, Wise RP, et al
    Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005.
    J Infect Dis. 2008;197 Suppl 2:S170-7.
    PubMed     Related articles    Abstract available
    
    
    
40. GALEA SA , Sweet A, Beninger P, Steinberg SP, et al
    The safety profile of varicella vaccine: a 10-year review.
    J Infect Dis. 2008;197 Suppl 2:S165-9.
    PubMed     Related articles    Abstract available
    
    
    
41. ZHOU F , Ortega-Sanchez IR, Guris D, Shefer A, et al
    An economic analysis of the universal varicella vaccination program in the United States.
    J Infect Dis. 2008;197 Suppl 2:S156-64.
    PubMed     Related articles    Abstract available
    
    
    
42. SHINEFIELD HR , Black S, Kuter BJ
    Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    J Infect Dis. 2008;197 Suppl 2:S152-5.
    PubMed     Related articles    Abstract available
    
    
    
43. BREUER J , Schmid DS, Gershon AA
    Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    J Infect Dis. 2008;197 Suppl 2:S147-51.
    PubMed     Related articles    Abstract available
    
    
    
44. WATSON B
    Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    J Infect Dis. 2008;197 Suppl 2:S143-6.
    PubMed     Related articles    Abstract available
    
    
    
45. BLACK S , Ray P, Shinefield H, Saddier P, et al
    Lack of association between age at varicella vaccination and risk of breakthrough varicella, within the Northern California Kaiser Permanente Medical Care Program.
    J Infect Dis. 2008;197 Suppl 2:S139-42.
    PubMed     Related articles    Abstract available
    
    
    
46. CHAVES SS , Zhang J, Civen R, Watson BM, et al
    Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005.
    J Infect Dis. 2008;197 Suppl 2:S127-31.
    PubMed     Related articles    Abstract available
    
    
    
47. PARKER AA , Reynolds MA, Leung J, Anderson M, et al
    Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement--Maine, 2006.
    J Infect Dis. 2008;197 Suppl 2:S101-7.
    PubMed     Related articles    Abstract available
    
    
    February 2008
48. SKOWRONSKI DM , Tweed SA, De Serres G
    Rapid Decline of Influenza Vaccine-Induced Antibody in the Elderly: Is It Real, or Is It Relevant?
    J Infect Dis. 2008;197:490-502.
    PubMed     Related articles    Abstract available
    
    
    
49. HE XS , Holmes TH, Mahmood K, Kemble GW, et al
    Phenotypic Changes in Influenza-Specific CD8(+) T Cells after Immunization of Children and Adults with Influenza Vaccines.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
50. THACKER E , Janke B
    Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas.
    J Infect Dis. 2008;197 Suppl 1:S19-24.
    PubMed     Related articles    Abstract available
    
    
    
51. FINEBERG HV
    Preparing for avian influenza: lessons from the "swine flu affair".
    J Infect Dis. 2008;197 Suppl 1:S14-8.
    PubMed     Related articles    Abstract available
    
    
    
52. MAIDEN MC , Ibarz-Pavon AB, Urwin R, Gray SJ, et al
    Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
53. STEPHENS DS
    Vaccines for the Unvaccinated: Protecting the Herd.
    J Infect Dis. 2008;.
    PubMed     Related articles   
    
    
    
54. MCGEE CE , Tsetsarkin K, Vanlandingham DL, McElroy KL, et al
    Substitution of Wild-Type Yellow Fever Asibi Sequences for 17D Vaccine Sequencesin ChimeriVax-Dengue 4 Does Not Enhance Infection of Aedes aegypti Mosquitoes.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
55. BERNSTEIN DI , Edwards KM, Dekker CL, Belshe R, et al
    Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
56. WRIGHT PF , Modlin JF
    The demise and rebirth of polio--a modern phoenix?
    J Infect Dis. 2008;197:335-6.
    PubMed     Related articles   
    
    
    January 2008
57. ZANGWILL KM , Treanor JJ, Campbell JD, Noah DL, et al
    Evaluation of the Safety and Immunogenicity of a Booster (Third) Dose of Inactivated Subvirion H5N1 Influenza Vaccine in Humans.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
58. ESTIVARIZ CF , Watkins MA, Handoko D, Rusipah R, et al
    A Large Vaccine-Derived Poliovirus Outbreak on Madura Island-Indonesia, 2005.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
59. D'SOUZA MP , Altfeld M
    Measuring HIV-1-Specific T Cell Immunity: How Valid Are Current Assays?
    J Infect Dis. 2008;.
    PubMed     Related articles   
    
    
    
60. DE VRIES-SLUIJS TE , Hansen BE, van Doornum GJ, Springeling T, et al
    A Prospective Open Study of the Efficacy of High-Dose Recombinant Hepatitis B Rechallenge Vaccination in HIV-Infected Patients.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
61. PERMAR SR , Rao SS, Sun Y, Bao S, et al
    Clinical measles after measles virus challenge in simian immunodeficiency virus-infected measles virus-vaccinated rhesus monkeys.
    J Infect Dis. 2007;196:1784-93.
    PubMed     Related articles    Abstract available
    
    
    
62. SOKAL EM , Hoppenbrouwers K, Vandermeulen C, Moutschen M, et al
    Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.
    J Infect Dis. 2007;196:1749-53.
    PubMed     Related articles    Abstract available
    
    
    
63. MARTIN JE , Pierson TC, Hubka S, Rucker S, et al
    A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial.
    J Infect Dis. 2007;196:1732-40.
    PubMed     Related articles    Abstract available
    
    
    
64. BALFOUR HH JR
    Epstein-Barr virus vaccine for the prevention of infectious mononucleosis--and what else?
    J Infect Dis. 2007;196:1724-6.
    PubMed     Related articles   
    
    
    
65. PETERSEN LR , Roehrig JT
    Flavivirus DNA vaccines--good science, uncertain future.
    J Infect Dis. 2007;196:1721-3.
    PubMed     Related articles   
    
    
    
66. MADHI SA , Adrian P, Kuwanda L, Cutland C, et al
    Long-Term Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization by Streptococcus pneumoniae--and Associated Interactions with Staphylococcus aureus and Haemophilus influenzae Colonization--in HIV-Infected and HIV-Uninfected Children.
    J Infect Dis. 2007;196:1662-1666.
    PubMed     Related articles    Abstract available
    
    
    
67. SCHNEIDER JA , Alam SA, Ackers M, Parekh B, et al
    Mucosal HIV-Binding Antibody and Neutralizing Activity in High-Risk HIV-Uninfected Female Participants in a Trial of HIV-Vaccine Efficacy.
    J Infect Dis. 2007;196:1637-1644.
    PubMed     Related articles    Abstract available
    
    
    
68. BRUNDAGE JF , Shanks GD
    What Really Happened during the 1918 Influenza Pandemic? The Importance of Bacterial Secondary Infections.
    J Infect Dis. 2007;196:1717-1718.
    PubMed     Related articles   
    
    
    
69. RIET EV , Adegnika AA, Retra K, Vieira R, et al
    Cellular and Humoral Responses to Influenza in Gabonese Children Living in Rural and Semi-Urban Areas.
    J Infect Dis. 2007;196:1671-1678.
    PubMed     Related articles    Abstract available
    
    
    November 2007
70. 
    Prophylactic Efficacy of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Women with Virological Evidence of HPV Infection.
    J Infect Dis. 2007;196:1438-1446.
    PubMed     Related articles    Abstract available
    
    
    
71. HILDESHEIM A , Herrero R
    Human Papillomavirus Vaccine Should Be Given before Sexual Debut for Maximum Benefit.
    J Infect Dis. 2007;196:1431-1432.
    PubMed     Related articles   
    
    
    
72. WARFIELD KL , Swenson DL, Olinger GG, Kalina WV, et al
    Ebola Virus-Like Particle-Based Vaccine Protects Nonhuman Primates against Lethal Ebola Virus Challenge.
    J Infect Dis. 2007;196 Suppl 2:S430-7.
    PubMed     Related articles    Abstract available
    
    
    
73. PATEL A , Zhang Y, Croyle M, Tran K, et al
    Mucosal Delivery of Adenovirus-Based Vaccine Protects against Ebola Virus Infection in Mice.
    J Infect Dis. 2007;196 Suppl 2:S413-20.
    PubMed     Related articles    Abstract available
    
    
    
74. JONES SM , Stroher U, Fernando L, Qiu X, et al
    Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of ebola virus hemorrhagic Fever.
    J Infect Dis. 2007;196 Suppl 2:S404-12.
    PubMed     Related articles    Abstract available
    
    
    
75. BINN LN , Sanchez JL, Gaydos JC
    Emergence of adenovirus type 14 in US military recruits--a new challenge.
    J Infect Dis. 2007;196:1436-7.
    PubMed     Related articles   
    
    
    
76. ORENSTEIN WA , Strebel PM, Hinman AR
    Building an immunity fence against measles.
    J Infect Dis. 2007;196:1433-5.
    PubMed     Related articles   
    
    
    
77. WARFIELD KL , Swenson DL, Olinger GG, Kalina WV, et al
    Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent.
    J Infect Dis. 2007;196 Suppl 2:S276-83.
    PubMed     Related articles    Abstract available
    
    
    
78. BAUSCH DG , Feldmann H, Geisbert TW, Bray M, et al
    Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient.
    J Infect Dis. 2007;196 Suppl 2:S136-41.
    PubMed     Related articles    Abstract available
    
    
    
79. HICKS LA , Harrison LH, Flannery B, Hadler JL, et al
    Incidence of Pneumococcal Disease Due to Non-Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998-2004.
    J Infect Dis. 2007;196:1346-54.
    PubMed     Related articles    Abstract available
    
    
    
80. NAIR N , Gans H, Lew-Yasukawa L, Long-Wagar AC, et al
    Age-Dependent Differences in IgG Isotype and Avidity Induced by Measles Vaccine Received during the First Year of Life.
    J Infect Dis. 2007;196:1339-45.
    PubMed     Related articles    Abstract available
    
    
    
81. DARNELL ME , Plant EP, Watanabe H, Byrum R, et al
    Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets.
    J Infect Dis. 2007;196:1329-38.
    PubMed     Related articles    Abstract available
    
    
    
82. ICHINOHE T , Tamura S, Kawaguchi A, Ninomiya A, et al
    Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine.
    J Infect Dis. 2007;196:1313-20.
    PubMed     Related articles    Abstract available
    
    
    
83. QIN L , Gilbert PB, Corey L, McElrath MJ, et al
    A framework for assessing immunological correlates of protection in vaccine trials.
    J Infect Dis. 2007;196:1304-12.
    PubMed     Related articles    Abstract available
    
    
    
84. SADOFF JC , Wittes J
    Correlates, surrogates, and vaccines.
    J Infect Dis. 2007;196:1279-81.
    PubMed     Related articles   
    
    
    
85. HANAGE WP
    Serotype replacement in invasive pneumococcal disease: where do we go from here?
    J Infect Dis. 2007;196:1282-4.
    PubMed     Related articles   
    
    
    October 2007
86. LIPSITCH M , O'Neill K, Cordy D, Bugalter B, et al
    Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine.
    J Infect Dis. 2007;196:1221-7.
    PubMed     Related articles    Abstract available
    
    
    
87. O'BRIEN KL , Millar EV, Zell ER, Bronsdon M, et al
    Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial.
    J Infect Dis. 2007;196:1211-20.
    PubMed     Related articles    Abstract available
    
    
    
88. GIULIANO AR , Lazcano-Ponce E, Villa L, Nolan T, et al
    Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine.
    J Infect Dis. 2007;196:1153-62.
    PubMed     Related articles    Abstract available
    
    
    
89. KIM JJ
    Vaccine policy analyses can benefit from natural history studies of human papillomavirus in men.
    J Infect Dis. 2007;196:1117-9.
    PubMed     Related articles   
    
    
    
90. HE Y , Manischewitz J, Meseda CA, Merchlinsky M, et al
    Antibodies to the A27 Protein of Vaccinia Virus Neutralize and Protect against Infection but Represent a Minor Component of Dryvax Vaccine-Induced Immunity.
    J Infect Dis. 2007;196:1026-32.
    PubMed     Related articles    Abstract available
    
    
    
91. TANG YW , Li H, Wu H, Shyr Y, et al
    Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine.
    J Infect Dis. 2007;196:1021-5.
    PubMed     Related articles    Abstract available
    
    
    
92. SENGUPTA N , Taha Y, Scott FT, Leedham-Green ME, et al
    Varicella-zoster-virus genotypes in East London: a prospective study in patients with herpes zoster.
    J Infect Dis. 2007;196:1014-20.
    PubMed     Related articles    Abstract available
    
    
    September 2007
93. JOKINEN S , Osterlund P, Julkunen I, Davidkin I, et al
    Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination.
    J Infect Dis. 2007;196:861-7.
    PubMed     Related articles    Abstract available
    
    
    
94. MIZRACHI NEBENZAHL Y , Bernstein A, Portnoi M, Shagan M, et al
    Streptococcus pneumoniae Surface-Exposed Glutamyl tRNA Synthetase, a Putative Adhesin, Is Able to Induce a Partially Protective Immune Response in Mice.
    J Infect Dis. 2007;196:945-53.
    PubMed     Related articles    Abstract available
    
    
    
95. KIM SH , Oh MD
    Persistence of cell-mediated immunity to vaccinia virus.
    J Infect Dis. 2007;196:805-6.
    PubMed     Related articles   
    
    
    
96. BREUER J , Quinlivan M, Al Bassam M, Macdonald S, et al
    DNA sequence variability in oka vaccine isolates.
    J Infect Dis. 2007;196:801-2.
    PubMed     Related articles   
    
    
    
97. GRIGOLEIT GU , Kapp M, Hebart H, Fick K, et al
    Dendritic Cell Vaccination in Allogeneic Stem Cell Recipients: Induction of Human Cytomegalovirus (HCMV)-Specific Cytotoxic T Lymphocyte Responses Even in Patients Receiving a Transplant from an HCMV-Seronegative Donor.
    J Infect Dis. 2007;196:699-704.
    PubMed     Related articles    Abstract available
    
    
    
98. ASTURIAS EJ , Dueger EL, Omer SB, Melville A, et al
    Randomized trial of inactivated and live polio vaccine schedules in guatemalan infants.
    J Infect Dis. 2007;196:692-8.
    PubMed     Related articles    Abstract available
    
    
    August 2007
99. TARUN AS , Dumpit RF, Camargo N, Labaied M, et al
    Protracted Sterile Protection with Plasmodium yoelii Pre-erythrocytic Genetically Attenuated Parasite Malaria Vaccines Is Independent of Significant Liver-Stage Persistence and Is Mediated by CD8+ T Cells.
    J Infect Dis. 2007;196:608-16.
    PubMed     Related articles    Abstract available
    
    
    
100. CONDACK C , Grivel JC, Devaux P, Margolis L, et al
     Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration.
     J Infect Dis. 2007;196:541-9.
     PubMed     Related articles    Abstract available
     
     
     
101. PEREZ-SCHAEL I , Salinas B, Tomat M, Linhares AC, et al
     Efficacy of the Human Rotavirus Vaccine RIX4414 in Malnourished Children.
     J Infect Dis. 2007;196:537-40.
     PubMed     Related articles    Abstract available
     
     
     
102. MOSS WJ , Scott S, Mugala N, Ndhlovu Z, et al
     Immunogenicity of Standard-Titer Measles Vaccinein HIV-1-Infected and Uninfected Zambian Children: An Observational Study.
     J Infect Dis. 2007;196:347-55.
     PubMed     Related articles    Abstract available
     
     
     
103. GALLAGHER KM , Juhasz M, Harris NS, Teshale EH, et al
     Predictors of Influenza Vaccination in HIV-Infected Patients in the United States, 1990-2002.
     J Infect Dis. 2007;196:339-46.
     PubMed     Related articles    Abstract available
     
     
     
104. HELFAND RF , Perry R, Strebel P
     Vaccines must be given in order to protect.
     J Infect Dis. 2007;196:333-5.
     PubMed     Related articles   
     
     
     July 2007
105. LAWRENCE SJ , Lottenbach KR, Newman FK, Buller RM, et al
     Antibody responses to vaccinia membrane proteins after smallpox vaccination.
     J Infect Dis. 2007;196:220-9.
     PubMed     Related articles    Abstract available
     
     
     
106. STANLEY SL JR , Frey SE, Taillon-Miller P, Guo J, et al
     The immunogenetics of smallpox vaccination.
     J Infect Dis. 2007;196:212-9.
     PubMed     Related articles    Abstract available
     
     
     
107. CROWE JE JR
     Genetic predisposition for adverse events after vaccination.
     J Infect Dis. 2007;196:176-7.
     PubMed     Related articles   
     
     
     
108. ROOK GA , Lowrie DB, Hernandez-Pando R
     Immunotherapeutics for tuberculosis in experimental animals: is there a common pathway activated by effective protocols?
     J Infect Dis. 2007;196:191-8.
     PubMed     Related articles    Abstract available
     
     
     
109. OLEINIKOV AV , Rossnagle E, Francis S, Mutabingwa TK, et al
     Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens.
     J Infect Dis. 2007;196:155-64.
     PubMed     Related articles    Abstract available
     
     
     
110. O'BRIEN KL , Moisi J, Moulton LH, Madore D, et al
     Predictors of Pneumococcal Conjugate Vaccine Immunogenicity among Infants and Toddlers in an American Indian PnCRM7 Efficacy Trial.
     J Infect Dis. 2007;196:104-14.
     PubMed     Related articles    Abstract available
     
     
     
111. KAJON AE , Moseley JM, Metzgar D, Huong HS, et al
     Molecular epidemiology of adenovirus type 4 infections in US military recruits in the postvaccination era (1997-2003).
     J Infect Dis. 2007;196:67-75.
     PubMed     Related articles    Abstract available
     
     
     June 2007
112. OTA MO , Ndhlovu Z, Oh S, Piyasirisilp S, et al
     Hemagglutinin Protein Is a Primary Target of the Measles Virus-Specific HLA-A2-Restricted CD8+ T Cell Response during Measles and after Vaccination.
     J Infect Dis. 2007;195:1799-807.
     PubMed     Related articles    Abstract available
     
     
     
113. BOELAERT JR , Vandecasteele SJ, Appelberg R, Gordeuk VR, et al
     The Effect of the Host's Iron Status on Tuberculosis.
     J Infect Dis. 2007;195:1745-53.
     PubMed     Related articles    Abstract available
     
     
     
114. MCDONALD WF , Huleatt JW, Foellmer HG, Hewitt D, et al
     A west nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
     J Infect Dis. 2007;195:1607-17.
     PubMed     Related articles    Abstract available
     
     
     
115. KREIJTZ JH , Suezer Y, van Amerongen G, de Mutsert G, et al
     Recombinant Modified Vaccinia Virus Ankara-Based Vaccine Induces Protective Immunity in Mice against Infection with Influenza Virus H5N1.
     J Infect Dis. 2007;195:1598-606.
     PubMed     Related articles    Abstract available
     
     
     
116. VAN DUIN D , Allore HG, Mohanty S, Ginter S, et al
     Prevaccine determination of the expression of costimulatory b7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults.
     J Infect Dis. 2007;195:1590-7.
     PubMed     Related articles    Abstract available
     
     
     May 2007
117. BEERNINK PT , Welsch JA, Harrison LH, Leipus A, et al
     Prevalence of Factor H-Binding Protein Variants and NadA among Meningococcal Group B Isolates from the United States: Implications for the Development of a Multicomponent Group B Vaccine.
     J Infect Dis. 2007;195:1472-9.
     PubMed     Related articles    Abstract available
     
     
     
118. ADAMS LV , Palumbo P
     The time to treat the children is now.
     J Infect Dis. 2007;195:1396-8.
     PubMed     Related articles   
     
     
     
119. MATSON DO
     On a multinational assessment of rotavirus disease in europe.
     J Infect Dis. 2007;195 Suppl 1:S1-3.
     PubMed     Related articles   
     
     
     April 2007
120. LANKOWSKI AJ , Hohmann EL
     Killed but metabolically active Salmonella typhimurium: application of a new technology to an old vector.
     J Infect Dis. 2007;195:1203-11.
     PubMed     Related articles    Abstract available
     
     
     March 2007
121. ROBERTS T , Beyers N, Aguirre A, Walzl G, et al
     Immunosuppression during Active Tuberculosis Is Characterized by Decreased Interferon- gamma Production and CD25 Expression with Elevated Forkhead Box P3, Transforming Growth Factor- beta , and Interleukin-4 mRNA Levels.
     J Infect Dis. 2007;195:870-8.
     PubMed     Related articles    Abstract available
     
     
     November 2006
122. FAUCI AS
     Seasonal and pandemic influenza preparedness: science and countermeasures.
     J Infect Dis. 2006;194 Suppl 2:S73-6.
     PubMed     Related articles    Abstract available
     
     
     
123. BLASER MJ
     Pandemics and preparations.
     J Infect Dis. 2006;194 Suppl 2:S70-2.
     PubMed     Related articles   
     
     
     
124. WHITLEY RJ , Monto AS
     Seasonal and pandemic influenza preparedness: a global threat.
     J Infect Dis. 2006;194 Suppl 2:S65-9.
     PubMed     Related articles    Abstract available
     
     
     
125. WHITLEY RJ , Bartlett J, Hayden FG, Pavia AT, et al
     Seasonal and pandemic influenza: recommendations for preparedness in the United States.
     J Infect Dis. 2006;194 Suppl 2:S155-61.
     PubMed     Related articles    Abstract available
     
     
     
126. WHITLEY RJ , Monto AS
     Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
     J Infect Dis. 2006;194 Suppl 2:S133-8.
     PubMed     Related articles    Abstract available
     
     
     August 2006
127. MACETE E , Aide P, Aponte JJ, Sanz S, et al
     Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in mozambican infants: a randomized, placebo-controlled trial.
     J Infect Dis. 2006;194:276-85.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: